In the world of structural biology, few tools have had as profound an impact as scFv16. This single-...

Commentary on everything related to cryo-EM in drug discovery.
In the world of structural biology, few tools have had as profound an impact as scFv16. This single-...
This month’s top posts, grouped by platform (Bluesky, X, and LinkedIn), showcase the latest cryo-EM ...
Clovertex’s January Target of the Month is Dopamine D2 Receptor (D2R), highlighted by Johnson & John...
Cryo-EM Twitter used to be an incredible place - a scientific hub chipping away at many of academia’...
Clovertex’s Target of the Year 2024 is the Gastric Inhibitory Polypeptide Receptor (GIPR), which has...
Clovertex’s December Target of the Month is the Dystrophin-Glycoprotein Complex (DGC), inspired by a...
Here are your MiTeGen Hottest Tweets in SBDD, with mesmerizing protein machinery structures and algo...
Clovertex’s November Target of the Month is Ninjurin 1 (NINJ1), selected in light of a recent cryo-E...
Here are your MiTeGen Hottest Tweets in SBDD, showcasing how laser flash melting might revolutionize...
Following this year’s Nobel Prize in Chemistry for breakthroughs in protein structure prediction and...